Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis

被引:182
作者
Bielekova, B
Sung, MH
Kadom, N
Simon, R
McFarland, H
Martin, R
机构
[1] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA
[2] NCI, Biometr Res Branch, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.172.6.3893
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis (MS) is an autoimmune disease in which myelin-specific T cells are believed to play a crucial pathogenic role. Nevertheless, so far it has been extremely difficult to demonstrate differences in T cell reactivity to myelin Ag between MS patients and controls. We believe that by using unphysiologically high Ag concentrations previous studies have missed a highly relevant aspect of autoimmune responses, i.e., T cells recognizing Ag with high functional avidity. Therefore, we focused on the characterization of high-avidity myelin-specific CD4(+) T cells in a large cohort of MS patients and controls that was matched demographically and with respect to expression of MHC class II alleles. We demonstrated that their frequency is significantly higher in MS patients while the numbers of control T cells specific for influenza hemagglutinin are virtually identical between the two cohorts; that high-avidity T cells are enriched for previously in vivo-activated cells and are significantly skewed toward a proinflammatory phenotype. Moreover, the immunodominant epitopes that were most discriminatory between MS patients and controls differed from those described previously and were clearly biased toward epitopes with lower predicted binding affinities to HLA-DR molecules, pointing at the importance of thymic selection for the generation of the autoimmune T cell repertoire. Correlations between selected immunological parameters and magnetic resonance imaging markers indicate that the specificity and function of these cells influences phenotypic disease expression. These data have important implications for autoimmunity research and should be considered in the development of Ag-specific therapies in MS.
引用
收藏
页码:3893 / 3904
页数:12
相关论文
共 53 条
  • [41] Immunology -: A new look at MHC and autoimmune disease
    Ridgway, WM
    Fassò, M
    Fathman, CG
    [J]. SCIENCE, 1999, 284 (5415) : 749 - +
  • [42] TARGET EPITOPES OF MYELIN BASIC-PROTEIN SPECIFIC T-CELL LINES IN MULTIPLE-SCLEROSIS
    RISTORI, G
    SALVETTI, M
    BUTTINELLI, C
    FALCONE, M
    TRABACE, S
    FIESCHI, C
    [J]. ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1993, 14 (02): : 139 - 143
  • [43] PREDOMINANT AND STABLE T-CELL RESPONSES TO REGIONS OF MYELIN BASIC-PROTEIN CAN BE DETECTED IN INDIVIDUAL PATIENTS WITH MULTIPLE-SCLEROSIS
    SALVETTI, M
    RISTORI, G
    DAMATO, M
    BUTTINELLI, C
    FALCONE, M
    FIESCHI, C
    WEKERLE, H
    POZZILLI, C
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (06) : 1232 - 1239
  • [44] A kinetic basis for T cell receptor repertoire selection during an immune response
    Savage, PA
    Boniface, JJ
    Davis, MM
    [J]. IMMUNITY, 1999, 10 (04) : 485 - 492
  • [45] Scholz C, 1998, J IMMUNOL, V160, P1532
  • [46] Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity
    Seamons, A
    Sutton, J
    Bai, D
    Baird, E
    Bonn, N
    Kafsack, BFC
    Shabanowitz, J
    Hunt, DF
    Beeson, C
    Goverman, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (10) : 1391 - 1397
  • [47] SUNG MH, 2003, IN PRESS METHODS BIO
  • [48] Endogenous myelin basic protein inactivates the high avidity T cell repertoire
    Targoni, OS
    Lehmann, PV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) : 2055 - 2063
  • [49] PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM MULTIPLE-SCLEROSIS PATIENTS RECOGNIZE MYELIN PROTEOLIPID PROTEIN AND SELECTED PEPTIDES
    TROTTER, JL
    HICKEY, WF
    VANDERVEEN, RC
    SULZE, L
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1991, 33 (01) : 55 - 62
  • [50] Perspective on antigen processing and presentation
    Unanue, ER
    [J]. IMMUNOLOGICAL REVIEWS, 2002, 185 : 86 - 102